Rafferty Asset Management, LLC Vanda Pharmaceuticals Inc. Transaction History

Rafferty Asset Management, LLC

$28.9 Billion
Q3 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	SELL	$5.9 - $6.95 $58,935 - $69,423	-9,989 Reduced 4.34%	220,097 $1.45 Million
Q1 2023 May 11, 2023	BUY	$6.18 - $7.99 $555,866 - $718,668	89,946 Added 64.18%	230,086 $1.56 Million
Q4 2022 Feb 13, 2023	BUY	$6.87 - $10.96 $20,431 - $32,595	2,974 Added 2.17%	140,140 $1.04 Million
Q3 2022 Nov 14, 2022	BUY	$9.44 - $11.76 $493,910 - $615,294	52,321 Added 61.67%	137,166 $1.36 Million
Q2 2022 Aug 12, 2022	SELL	$9.31 - $11.84 $814,410 - $1.04 Million	-87,477 Reduced 50.76%	84,845 $925,000
Q1 2022 May 13, 2022	BUY	$10.84 - $16.55 $456,635 - $697,168	42,125 Added 32.35%	172,322 $1.95 Million
Q4 2021 Feb 10, 2022	BUY	$15.69 - $21.14 $761,875 - $1.03 Million	48,558 Added 59.48%	130,197 $2.04 Million
Q3 2021 Nov 10, 2021	BUY	$15.35 - $21.27 $129,369 - $179,263	8,428 Added 11.51%	81,639 $1.4 Million
Q2 2021 Aug 10, 2021	SELL	$15.71 - $21.51 $439,722 - $602,064	-27,990 Reduced 27.66%	73,211 $1.58 Million
Q1 2021 May 10, 2021	BUY	$13.42 - $20.28 $1.05 Million - $1.58 Million	77,871 Added 333.78%	101,201 $1.52 Million
Q4 2020 Feb 10, 2021	SELL	$9.77 - $13.81 $410,965 - $580,903	-42,064 Reduced 64.32%	23,330 $307,000
Q3 2020 Nov 13, 2020	BUY	$9.32 - $12.02 $283,076 - $365,083	30,373 Added 86.73%	65,394 $632,000
Q2 2020 Aug 07, 2020	BUY	$9.66 - $12.02 $338,302 - $420,952	35,021 New	35,021 $401,000
Q1 2020 May 15, 2020	SELL	$7.5 - $16.8 $396,435 - $888,014	-52,858 Closed	0 $0
Q4 2019 Feb 10, 2020	SELL	$12.38 - $17.47 $1.07 Million - $1.51 Million	-86,598 Reduced 62.1%	52,858 $867,000
Q3 2019 Nov 14, 2019	SELL	$12.27 - $15.79 $73,963 - $95,182	-6,028 Reduced 4.14%	139,456 $1.85 Million
Q2 2019 Aug 09, 2019	SELL	$13.37 - $18.85 $258,950 - $365,086	-19,368 Reduced 11.75%	145,484 $2.05 Million
Q1 2019 May 15, 2019	BUY	$17.59 - $31.05 $2.9 Million - $5.12 Million	164,852 New	164,852 $3.03 Million

Others Institutions Holding VNDA

# of Institutions

157

Shares Held

44.9M

Call Options Held

165K

Put Options Held

33.6K

Black Rock Inc. New York, NY

8.14M
Shares

$35.9 Million
0.0% of portfolio
Jim Simons Renaissance Technologies LLC | New York, Ny

4.01M
Shares

$17.7 Million
0.03% of portfolio
Vanguard Group Inc Valley Forge, PA

3.63M
Shares

$16 Million
0.0% of portfolio
Tang Capital Management LLC San Diego, CA

2.35M
Shares

$10.4 Million
0.94% of portfolio
Dimensional Fund Advisors LP Austin, TX

2.26M
Shares

$9.97 Million
0.0% of portfolio

View Full List

About Vanda Pharmaceuticals Inc.

Ticker VNDA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,561,500
Market Cap $249M
Description
Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs. The company's marketed products include HETLIOZ for the treatment of non-24-hour sleep-wake disorders; and Fanapt oral tablets for the treatment of schizophrenia. Its products under developme...

More about VNDA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rafferty Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Rafferty Asset Management, LLC with notifications on news.

Account